Twist Bioscience Revenue and Competitors

Location

$503.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Twist Bioscience's estimated annual revenue is currently $132.3M per year.(i)
  • Twist Bioscience received $50.0M in venture funding in April 2018.
  • Twist Bioscience's estimated revenue per employee is $102,900
  • Twist Bioscience's total funding is $503.1M.
  • Twist Bioscience's current valuation is $3B. (January 2022)

Employee Data

  • Twist Bioscience has 1286 Employees.(i)
  • Twist Bioscience grew their employee count by -3% last year.

Twist Bioscience's People

NameTitleEmail/Phone
1
Chief Accounting Officer (CAO)Reveal Email/Phone
2
CFOReveal Email/Phone
3
CEO and Co-FounderReveal Email/Phone
4
VP Supply ChainReveal Email/Phone
5
VP Product DevelopmentReveal Email/Phone
6
VP, Chief Accounting OfficerReveal Email/Phone
7
SVP Human ResourcesReveal Email/Phone
8
General Counsel & Chief Ethics & Compliance OfficerReveal Email/Phone
9
VP NGS Applications & Business DevelopmentReveal Email/Phone
10
VP Sales AMER & EMEAReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14M100-12%$27.2MN/A
#2
$13.4M55N/AN/AN/A
#3
$1M12N/AN/AN/A
#4
$3.5M43N/AN/AN/A
#5
$24.9M156N/AN/AN/A
#6
$14.7M95-26%$1.4MN/A
#7
$3.3M28N/AN/AN/A
#8
$141.7M65311%$1.35BN/A
#9
$2.8M28N/AN/AN/A
#10
$76.3M436N/AN/AN/A
#11
$8.8M35N/AN/AN/A
#12
$1321M5263N/AN/AN/A
#13
$102.3M334N/AN/AN/A
Add Company

What Is Twist Bioscience?

Twist Bioscience is a synthetic biology company based in San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise unavailable. Our technology overcomes inefficiencies and enables cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing. We offer both the quality and quantity researchers need now to rapidly realize opportunities ahead. Twitter @TwistBioscience Facebook facebook.com/TwistBioscience YouTube youtube.com/TwistBioscience #WeMakeDNA

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power

$503.1M

Total Funding

1286

Number of Employees

$132.3M

Revenue (est)

-3%

Employee Growth %

$3B

Valuation

N/A

Accelerator

Twist Bioscience News

2022-04-20 - Twist Bioscience Launches High Throughput Antibody ...

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform...

2022-04-13 - Twist Bioscience to Report Fiscal 2022 Second Quarter ...

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis...

2022-04-13 - Twist Bioscience to Become Voting Member of Storage ...

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis...

2021-03-22 - Twist Bioscience Functional GLP-1R Antibodies Identified From Its Proprietary Synthetic DNA GPCR Libraries Demonstrate Potent Blood Glucose Control

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 22, 2021-- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced positive preclinical data demonstrating that GLP-1R an ...

2021-03-15 - Twist Bioscience Begins Shipping of Synthetic RNA Controls for B.1.351 and P.1 Variants

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 15, 2021-- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its new synthetic RNA ref ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$261.9M129019%N/A
#2
N/A132816%N/A
#3
$154.2M13316%$557.3M
#4
$279.7M13325%N/A
#5
$474M1333-1%N/A

Twist Bioscience Funding

DateAmountRoundLead InvestorsReference
2014-02-13$9.1MAArticle
2014-05-28$26.0MBTao InvestArticle
2014-10-01$10.0MUndisclosedSilicon Valley BankArticle
2015-06-11$37.0MCIllumina IncArticle
2016-01-20$61.0MDMultipleArticle
2017-03-28$33.0MUndisclosedArticle
2017-06-15$27.0MUndisclosedArticle
2018-04-03$50.0MUndisclosedArticle